# US 2022/0023361 A1 · Composition against resistant organisms (mrsa)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0023361 A1
- Document ID: US20220023361A1
- Status: Published application
- Kind: A1
- Application number: 17/277,592
- Filed: 2019-09-18
- Published: 2022-01-27
- Earliest claimed: 2018-09-19
- Assignees: FermentationExperts A/S
- Applicants: FermentationExperts A/S
- Inventors: Søren Kjærulff
- Web page: https://patentgrep.com/patent/US20220023361A1

## CPC

- A61K 36/03: Phaeophycota or phaeophyta (brown algae), e.g. Fucus
- A23B 2/729: Organic compounds; Microorganisms; Enzymes
- A23B 2/733: Compounds of undetermined constitution obtained from animals or plants
- A23B 2/783: Microorganisms; Enzymes
- A23B 7/10: Preserving with acids; Acid fermentation
- A23K 10/12: by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
- A23K 10/16: Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions (A23K10/12 takes precedence)
- A23K 10/18: of live microorganisms
- A23K 10/30: from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms (obtained by microbiological or biochemical processes, e.g. using yeasts or enzymes, A23K10/10)
- A23K 40/10: by agglomeration; by granulation, e.g. making powders
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K 35/745: Bifidobacteria
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 36/02: Algae
- A61K 36/04: Rhodophycota or rhodophyta (red algae), e.g. Porphyra
- A61P 31/04: Antibacterial agents
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23B: PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23K: FODDER
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A composition comprises: (i) at least one fermented seaweed material; (ii) at least one fermented plant material: or (iii) a combination of at least one fermented seaweed material and at least one fermented plant material; and at least one lactic acid bacterial strain, for treating, alleviating, suppressing and/or preventing growth of a resistant organism.

## Claims

### Claim 1

A composition comprising:
(i) at least one fermented seaweed material;
(ii) at least one fermented plant material: or
(iii) a combination of at least one fermented seaweed material and at least one fermented plant material;
and at least one lactic acid bacterial strain, for use in treating, alleviating, suppressing and/or preventing growth of a resistant organism.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition comprises one or more lactic acid bacterial strains, such as two or more lactic acid bacterial strains, such as three or more lactic acid bacterial strains, such as four or more lactic acid bacterial strains, such as 7 or more lactic acid bacterial strains, such as 10 or more lactic acid bacterial strains, such as 15 or more lactic acid bacterial strains, such as 20 or more lactic acid bacterial strains, such as 25 or more lactic acid bacterial strains, such as 30 or more lactic acid bacterial strains, such as 35 or more lactic acid bacterial strains, such as 40 or more lactic acid bacterial strains.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the at least one seaweed material is performed for at least 2 days.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the seaweed material is a unicellular alga or a multicellular macroalgae and wherein the multicellular macroalgae is selected from brown macroalgae and/or red macroalgae.

### Claim 5 (depends on 4)

The composition according to claim 4, wherein the brown macroalgae is selected from one or more of kelps, Saccharina latissimi (Laminaria saccharina), Laminaria digitate, Ascophyllum nodosum, Laminaria hyperborean, or a mixture hereof.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the resistant organism is a resistant bacterium.

### Claim 7 (depends on 6)

The composition according to claim 6, wherein the resistant bacterium is a resistant Staphylococcus aureus.

### Claim 8 (depends on 7)

The composition according to claim 7, wherein the resistant Staphylococcus aureus is a methicillin-resistant Staphylococcus aureus (MRSA) or a oxacillin-resistant Staphylococcus aureus (ORSA).

### Claim 9 (depends on 1)

The composition according to claim 1, wherein the composition is for the treatment, alleviation, suppression, and/or prevention of growth of a resistant organism in a human or in an animal or in a room, wherein the room may be a hospital room, a barn, a stable, a prison, a nursing home or a cage.

### Claim 10 (depends on 1)

The composition according to claim 1, wherein the composition comprises a fibrous material.

### Claim 11 (depends on 1)

An animal feed product comprising a composition according to claim 1.

### Claim 12 (depends on 11)

The animal feed product according to claim 11, wherein the animal feed product is mixed with a basic feed compound and formed as a free-flowing powder or as an animal feed pellet.
